Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Janiel Cragun
Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Obstetrics and Gynecology
Full Page
Overview
Research
More
Collaboration
(8)
Setsuko Chambers
Mutual work: 7 Proposals﹒5 Grants﹒2 Publications
Collaboration Details
Hina Arif Tiwari
Mutual work: 2 Publications
Collaboration Details
Carolyn Lane
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Mitzi Miranda
Mutual work: 5 Grants﹒7 Proposals
Collaboration Details
Aradhana Kari
Mutual work: 4 Grants﹒6 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(8)
Sign in to view all grants
Page 1 of 2
Previous page
Next page
Publications
(39)
Recent
miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk
2024
microrna,
ovarian cancer,
biomarkers,
risk mitigation
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk
2024
ovarian cancer,
cancer risk
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
2022
ovarian cancer,
chemotherapy,
clinical trial,
drug combination,
platinum-resistant cancer
Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without or Mutations
2019
chemotherapy,
hypersensitivity,
ovarian cancer,
genetic mutations,
peritoneal cancer
Incidence of Hypersensitivity Reactions to Carboplatin in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer with or without BRCA1 or BRCA2 Mutations
2018
cancer,
hypersensitivity,
carboplatin,
ovarian cancer
An Interdisciplinary program to prevent postoperative pneumonia: An Evidenced-Based Project.
2018
interdisciplinary program,
postoperative pneumonia,
healthcare interventions
The utility of patient reported data in a gynecologic oncology clinic
2018
gynecologic oncology,
clinical outcomes,
healthcare quality,
patient-centered care
Simple Patient Care Instructions Translate Best: Safety Guidelines for Physician Use of Google Translate
2017
patient care,
language translation,
physician guidelines,
safety,
google translate
Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deesequencing of circulating tumor DNA ctDNA) in women with high grade serous carcinoma on the ARIEL2 trial ABSTRACT
2016
oncology,
cancer genetics,
clinical trials,
biomarker analysis,
precision medicine
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma ARIEL2 Part 1) an international, multicentre, open-label, phase 2 trial
2016
ovarian cancer,
clinical trial,
platinum-sensitive,
rucaparib
